N-[[(1R)-2,2-difluoro-1-methylcyclopropyl]methyl]-2-(4,4-difluoropiperidin-1-yl)-6-methoxy-7-(3-pyrrolidin-1-ylpropoxy)quinazolin-4-amine;2-(4,4-difluoropiperidin-1-yl)-N-(1H-indol-3-yl)-6-methoxy-7-(3-pyrrolidin-1-ylpropoxy)quinazolin-4-amine;2-(4,4-difluoropiperidin-1-yl)-6-methoxy-N-[(3R)-3-(3-methylbutyl)oxan-3-yl]-7-(3-pyrrolidin-1-ylpropoxy)quinazolin-4-amine;(3S,4R)-4-[[(1R)-1-[[2-(4,4-difluoropiperidin-1-yl)-6-methoxy-7-(3-pyrrolidin-1-ylpropoxy)quinazolin-4-yl]amino]ethyl]amino]oxolan-3-ol
C113H156F10N22O11 — CID 163437670
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-[[(1R)-2,2-difluoro-1-methylcyclopropyl]methyl]-2-(4,4-difluoropiperidin-1-yl)-6-methoxy-7-(3-pyrrolidin-1-ylpropoxy)quinazolin-4-amine;2-(4,4-difluoropiperidin-1-yl)-N-(1H-indol-3-yl)-6-methoxy-7-(3-pyrrolidin-1-ylpropoxy)quinazolin-4-amine;2-(4,4-difluoropiperidin-1-yl)-6-methoxy-N-[(3R)-3-(3-methylbutyl)oxan-3-yl]-7-(3-pyrrolidin-1-ylpropoxy)quinazolin-4-amine;(3S,4R)-4-[[(1R)-1-[[2-(4,4-difluoropiperidin-1-yl)-6-methoxy-7-(3-pyrrolidin-1-ylpropoxy)quinazolin-4-yl]amino]ethyl]amino]oxolan-3-ol
N-[[(1R)-2,2-difluoro-1-methylcyclopropyl]methyl]-2-(4,4-difluoropiperidin-1-yl)-6-methoxy-7-(3-pyrrolidin-1-ylpropoxy)quinazolin-4-amine;2-(4,4-difluoropiperidin-1-yl)-N-(1H-indol-3-yl)-6-methoxy-7-(3-pyrrolidin-1-ylpropoxy)quinazolin-4-amine;2-(4,4-difluoropiperidin-1-yl)-6-methoxy-N-[(3R)-3-(3-methylbutyl)oxan-3-yl]-7-(3-pyrrolidin-1-ylpropoxy)quinazolin-4-amine;(3S,4R)-4-[[(1R)-1-[[2-(4,4-difluoropiperidin-1-yl)-6-methoxy-7-(3-pyrrolidin-1-ylpropoxy)quinazolin-4-yl]amino]ethyl]amino]oxolan-3-ol (PubChem CID 163437670) has the molecular formula C113H156F10N22O11 and a molecular weight of 2188.61 g/mol. Its IUPAC name is N-[[(1R)-2,2-difluoro-1-methylcyclopropyl]methyl]-2-(4,4-difluoropiperidin-1-yl)-6-methoxy-7-(3-pyrrolidin-1-ylpropoxy)quinazolin-4-amine;2-(4,4-difluoropiperidin-1-yl)-N-(1H-indol-3-yl)-6-methoxy-7-(3-pyrrolidin-1-ylpropoxy)quinazolin-4-amine;2-(4,4-difluoropiperidin-1-yl)-6-methoxy-N-[(3R)-3-(3-methylbutyl)oxan-3-yl]-7-(3-pyrrolidin-1-ylpropoxy)quinazolin-4-amine;(3S,4R)-4-[[(1R)-1-[[2-(4,4-difluoropiperidin-1-yl)-6-methoxy-7-(3-pyrrolidin-1-ylpropoxy)quinazolin-4-yl]amino]ethyl]amino]oxolan-3-ol.
Molecular Properties
| Compound Name | N-[[(1R)-2,2-difluoro-1-methylcyclopropyl]methyl]-2-(4,4-difluoropiperidin-1-yl)-6-methoxy-7-(3-pyrrolidin-1-ylpropoxy)quinazolin-4-amine;2-(4,4-difluoropiperidin-1-yl)-N-(1H-indol-3-yl)-6-methoxy-7-(3-pyrrolidin-1-ylpropoxy)quinazolin-4-amine;2-(4,4-difluoropiperidin-1-yl)-6-methoxy-N-[(3R)-3-(3-methylbutyl)oxan-3-yl]-7-(3-pyrrolidin-1-ylpropoxy)quinazolin-4-amine;(3S,4R)-4-[[(1R)-1-[[2-(4,4-difluoropiperidin-1-yl)-6-methoxy-7-(3-pyrrolidin-1-ylpropoxy)quinazolin-4-yl]amino]ethyl]amino]oxolan-3-ol |
|---|---|
| PubChem CID | 163437670 |
| Molecular Formula | C113H156F10N22O11 |
| Molecular Weight | 2188.61 g/mol |
| Exact Mass | 2187.22 |
| IUPAC Name | N-[[(1R)-2,2-difluoro-1-methylcyclopropyl]methyl]-2-(4,4-difluoropiperidin-1-yl)-6-methoxy-7-(3-pyrrolidin-1-ylpropoxy)quinazolin-4-amine;2-(4,4-difluoropiperidin-1-yl)-N-(1H-indol-3-yl)-6-methoxy-7-(3-pyrrolidin-1-ylpropoxy)quinazolin-4-amine;2-(4,4-difluoropiperidin-1-yl)-6-methoxy-N-[(3R)-3-(3-methylbutyl)oxan-3-yl]-7-(3-pyrrolidin-1-ylpropoxy)quinazolin-4-amine;(3S,4R)-4-[[(1R)-1-[[2-(4,4-difluoropiperidin-1-yl)-6-methoxy-7-(3-pyrrolidin-1-ylpropoxy)quinazolin-4-yl]amino]ethyl]amino]oxolan-3-ol |
| SMILES | COc1cc2c(NC[C@@]3(C)CC3(F)F)nc(N3CCC(F)(F)CC3)nc2cc1OCCCN1CCCC1.COc1cc2c(N[C@H](C)N[C@@H]3COC[C@H]3O)nc(N3CCC(F)(F)CC3)nc2cc1OCCCN1CCCC1.COc1cc2c(N[C@]3(CCC(C)C)CCCOC3)nc(N3CCC(F)(F)CC3)nc2cc1OCCCN1CCCC1.COc1cc2c(Nc3c[nH]c4ccccc34)nc(N3CCC(F)(F)CC3)nc2cc1OCCCN1CCCC1 |
| InChI | InChI=1S/C31H47F2N5O3.C29H34F2N6O2.C27H40F2N6O4.C26H35F4N5O2/c1-23(2)8-10-30(9-6-18-40-22-30)36-28-24-20-26(39-3)27(41-19-7-15-37-13-4-5-14-37)21-25(24)34-29(35-28)38-16-11-31(32,33)12-17-38;1-38-25-17-21-23(18-26(25)39-16-6-13-36-11-4-5-12-36)34-28(37-14-9-29(30,31)10-15-37)35-27(21)33-24-19-32-22-8-3-2-7-20(22)24;1-18(30-21-16-38-17-22(21)36)31-25-19-14-23(37-2)24(39-13-5-10-34-8-3-4-9-34)15-20(19)32-26(33-25)35-11-6-27(28,29)7-12-35;1-24(16-26(24,29)30)17-31-22-18-14-20(36-2)21(37-13-5-10-34-8-3-4-9-34)15-19(18)32-23(33-22)35-11-6-25(27,28)7-12-35/h20-21,23H,4-19,22H2,1-3H3,(H,34,35,36);2-3,7-8,17-19,32H,4-6,9-16H2,1H3,(H,33,34,35);14-15,18,21-22,30,36H,3-13,16-17H2,1-2H3,(H,31,32,33);14-15H,3-13,16-17H2,1-2H3,(H,31,32,33)/t30-;;18-,21-,22-;24-/m0.11/s1 |
| InChIKey | AVWBKRANFKJTJA-AVICZRDPSA-N |
| XLogP | 20.14 |
| TPSA | 317.51 Ų |
| H-Bond Donors | 7 |
| H-Bond Acceptors | 32 |
| Rotatable Bonds | 42 |
| Heavy Atoms | 156 |
| Complexity | — |
Lipinski Rule of Five
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2188.61 |
| LogP ≤ 5 | 20.14 |
| H-Bond Donors ≤ 5 | 7 |
| H-Bond Acceptors ≤ 10 | 32 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'het-C-het_not_in_ring', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 163437670 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.